Ht-Logo-gigapixel-icon
Thursday, November 21, 2024
Canada’s Politics and Government News Source Since 1989
Thursday, November 21, 2024 | Latest Paper

Steven Globerman

FDA approval may spell trouble for Canadian patients

Opinion | BY STEVEN GLOBERMAN | January 10, 2024
U.S. Food and Drug Administration Commissioner Robert M. Califf, left, and Health Minister Mark Holland. Legalized importing of drugs from Canada into the U.S. could reduce the availability of drugs here, but not for the reasons you might think, writes Steven Globerman. Photograph courtesy of the U.S. FDA and The Hill Times photograph by Andrew Meade
Opinion | BY STEVEN GLOBERMAN | January 10, 2024
Opinion | BY STEVEN GLOBERMAN | January 10, 2024
U.S. Food and Drug Administration Commissioner Robert M. Califf, left, and Health Minister Mark Holland. Legalized importing of drugs from Canada into the U.S. could reduce the availability of drugs here, but not for the reasons you might think, writes Steven Globerman. Photograph courtesy of the U.S. FDA and The Hill Times photograph by Andrew Meade
Opinion | BY STEVEN GLOBERMAN | January 10, 2024
U.S. Food and Drug Administration Commissioner Robert M. Califf, left, and Health Minister Mark Holland. Legalized importing of drugs from Canada into the U.S. could reduce the availability of drugs here, but not for the reasons you might think, writes Steven Globerman. Photograph courtesy of the U.S. FDA and The Hill Times photograph by Andrew Meade
Opinion | BY STEVEN GLOBERMAN | January 10, 2024
Opinion | BY STEVEN GLOBERMAN | January 10, 2024
U.S. Food and Drug Administration Commissioner Robert M. Califf, left, and Health Minister Mark Holland. Legalized importing of drugs from Canada into the U.S. could reduce the availability of drugs here, but not for the reasons you might think, writes Steven Globerman. Photograph courtesy of the U.S. FDA and The Hill Times photograph by Andrew Meade
Opinion | BY STEVEN GLOBERMAN | October 16, 2023
United States Trade Representative Katherine Tai, left, and International Trade Minister Mary Ng hold a joint press conference in Ottawa on May 5, 2022. Among the reasons for focusing on our southern neighbour, the potential market in the U.S. for Canadian services exports dwarfs those in Indo-Pacific countries, writes Steven Globerman. The Hill Times photograph by Andrew Meade
Opinion | BY STEVEN GLOBERMAN | October 16, 2023
Opinion | BY STEVEN GLOBERMAN | October 16, 2023
United States Trade Representative Katherine Tai, left, and International Trade Minister Mary Ng hold a joint press conference in Ottawa on May 5, 2022. Among the reasons for focusing on our southern neighbour, the potential market in the U.S. for Canadian services exports dwarfs those in Indo-Pacific countries, writes Steven Globerman. The Hill Times photograph by Andrew Meade